Literature DB >> 12638907

Exposure of anionic phospholipids serves as anti-inflammatory and immunosuppressive signal--implications for antiphospholipid syndrome and systemic lupus erythematosus.

Udo S Gaipl1, Thomas D Beyer, Irith Baumann, Reinhard E Voll, Christian M Stach, Petra Heyder, Joachim R Kalden, Angelo Manfredi, Martin Herrmann.   

Abstract

In contrast to necrotic cells, the clearance of apoptotic ones usually is an anti-inflammatory process which elicits only a marginal immune response. During apoptosis phosphatidylserine (PS) is exposed on the outer leaflet of the cytoplasmic membrane and serves as target for the PS receptor of phagocytes. The latter is responsible for anti-inflammatory signalling and the induction of TGFbeta. We were interested whether the immunogenicity of apoptotic cells can be increased by masking PS. We observed that treatment of xenogeneic apoptotic cells with annexin V (AxV) significantly increased the humoral immune response against surface epitopes of these cells. Furthermore, AxV-coated irradiated tumour cells were able to elicit a long lasting tumour specific cytotoxic T lymphocyte response. AxV efficiently blocked the uptake of irradiated cells by macrophages but not by dendritic cells. Furthermore, AxV skewed the phagocytosis of irradiated cells towards inflammation. Investigation of patients with autoimmune diseases further supported the role of anionic surface phospholipids for anti-inflammatory clearance of apoptotic cells. Impaired clearance and opsonisation with anti-phospholipid-antibodies are discussed to be responsible for the development of systemic lupus erythematosus and anti-phospholipid-syndrome, respectively. Presentation of cryptic epitopes from late apoptotic cells in a proinflammatory context may challenge T cell tolerance. In addition, accumulation of uncleared apoptotic debris in the germinal centres of lymph nodes may result in the survival of autoreactive B cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12638907     DOI: 10.1078/0171-2985-00217

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  14 in total

1.  Peripheral blood lymphocyte apoptosis and circulating dendritic cells in patients with systemic lupus erythematosus: correlation with immunological status and disease-related symptoms.

Authors:  Ewa Robak; Anna Sysa-Jedrzejowska; Tadeusz Robak; Piotr Smolewski
Journal:  Clin Rheumatol       Date:  2006-01-24       Impact factor: 2.980

2.  Efficacy and Safety of Bavituximab in Combination with Sorafenib in Advanced Hepatocellular Carcinoma: A Single-Arm, Open-Label, Phase II Clinical Trial.

Authors:  Ali A Mokdad; Hao Zhu; Muhammad S Beg; Yull Arriaga; Jonathan E Dowell; Amit G Singal; Adam C Yopp
Journal:  Target Oncol       Date:  2019-10       Impact factor: 4.493

3.  [An impaired detection and clearance of dying cells can lead to the development of chronic autoimmunity].

Authors:  L E Munoz; M Herrmann; U S Gaipl
Journal:  Z Rheumatol       Date:  2005-09       Impact factor: 1.372

4.  Anti-phospholipid antibodies in serum from patients with Guillain-Barré syndrome.

Authors:  G Nakos; E Tziakou; L Maneta-Peyret; C Nassis; M E Lekka
Journal:  Intensive Care Med       Date:  2005-07-26       Impact factor: 17.440

Review 5.  Dendritic cells: an important link between antiphospholipid antibodies, endothelial dysfunction, and atherosclerosis in autoimmune and non-autoimmune diseases.

Authors:  Anna Broder; Jimmy J Chan; Chaim Putterman
Journal:  Clin Immunol       Date:  2012-12-20       Impact factor: 3.969

6.  Cell surface-expressed phosphatidylserine as therapeutic target to enhance phagocytosis of apoptotic cells.

Authors:  K Schutters; D H M Kusters; M L L Chatrou; T Montero-Melendez; M Donners; N M Deckers; D V Krysko; P Vandenabeele; M Perretti; L J Schurgers; C P M Reutelingsperger
Journal:  Cell Death Differ       Date:  2012-09-07       Impact factor: 15.828

Review 7.  Molecular imaging metrics to evaluate response to preclinical therapeutic regimens.

Authors:  R Adam Smith; Saffet Guleryuz; H Charles Manning
Journal:  Front Biosci (Landmark Ed)       Date:  2011-01-01

8.  Human macrophages and dendritic cells can equally present MART-1 antigen to CD8(+) T cells after phagocytosis of gamma-irradiated melanoma cells.

Authors:  María Marcela Barrio; Riad Abes; Marina Colombo; Gabriela Pizzurro; Charlotte Boix; María Paula Roberti; Emmanuelle Gélizé; Mariana Rodriguez-Zubieta; José Mordoh; Jean-Luc Teillaud
Journal:  PLoS One       Date:  2012-07-02       Impact factor: 3.240

Review 9.  The immune functions of phosphatidylserine in membranes of dying cells and microvesicles.

Authors:  Benjamin Frey; Udo S Gaipl
Journal:  Semin Immunopathol       Date:  2010-10-13       Impact factor: 11.759

10.  Monocyte-derived dendritic cells loaded with a mixture of apoptotic/necrotic melanoma cells efficiently cross-present gp100 and MART-1 antigens to specific CD8(+) T lymphocytes.

Authors:  Erika M von Euw; María M Barrio; David Furman; Michele Bianchini; Estrella M Levy; Cassian Yee; Yongqing Li; Rosa Wainstok; José Mordoh
Journal:  J Transl Med       Date:  2007-04-20       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.